Inovio Pharmaceuticals (INO) Notes Payables (2024 - 2026)
Inovio Pharmaceuticals (INO) posted Notes Payables of $24.9 million for Q1 2026, down 14.23% sequentially from $29.1 million in Q4 2025, and up 161.25% YoY from $9.5 million in Q1 2025.
Inovio Pharmaceuticals (INO) Notes Payables (2024 - 2026) Analysis & Trends
Inovio Pharmaceuticals has reported Notes Payables for 3 years, with the latest figure at $24.9 million in Q1 2026.
- Quarterly Notes Payables rose 161.25% year-over-year to $24.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.9 million (up 161.25% YoY) and the FY2025 annual result came in at $29.1 million, up 119.29% from the prior year.
- Notes Payables declined to $24.9 million in Q1 2026 per INO's latest filing, from $29.1 million in the prior quarter.
- Over five years, Notes Payables peaked at $50.4 million in Q3 2025 and troughed at $9.5 million in Q1 2025.
- A 3-year average of $23.1 million and a median of $19.1 million in 2024 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2025 and 2026: Notes Payables soared 119.29% in 2025, then jumped 161.25% in 2026.
- Over 3 years, Notes Payables stood at $13.3 million in 2024, then jumped by 119.29% to $29.1 million in 2025, then fell by 14.23% to $24.9 million in 2026.
- According to Business Quant data, Notes Payables over the past three periods registered $24.9 million, $29.1 million, and $50.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Inovio Pharmaceuticals | 96.32 Mn | 96.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.02 Mn |
| Mar 31, 2026 | 24.93 Mn |
| Dec 31, 2025 | 29.07 Mn |
| Sep 30, 2025 | 50.38 Mn |
| Jun 30, 2025 | 11.42 Mn |
| Mar 31, 2025 | 9.54 Mn |
| Dec 31, 2024 | 13.26 Mn |